IP Library › Granted Patent US 10,369,182
Granted Patent B2
US 10,369,182 · App. 16/026,541 · Granted Aug 6, 2019

Compositions and methods for treating insomnia and other sleep related disorders

Inventor: Suzy Cohen (Broomfield, CO)
Assignee: SCRIPT ESSENTIALS, LLC
A61K36/53A23L33/10A23L33/105A23L33/15A23L33/175A61K9/0053A61K9/20A61K9/2068A61K9/48A61K9/4875A61K31/00A61K31/197A61K31/198A61K31/405A61K31/4045A61K31/4415A61K31/675A61K36/185A61K36/28A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,369,182
App. No.
16/026,541
Granted
Aug 6, 2019
Kind
B2
Abstract

The present disclosure is a composition, a method of making the composition and method of using such composition preferably in the form of a dietary supplement that, when administered, is capable of treating insomnia and other sleep-related disorders. The unique combination of the composition is preferably administered orally. The composition is preferably comprised of at least vitamin B6, chamomile extract, passionflower extract, lemon balm extract, L-Theanine, GABA, 5-Hydroxytryptophan, and melatonin, in pre-determined amounts. The composition can further comprise a palliative agent, and can be provided in the form of a capsule, powder, liquid or tablet.

Claims (23)

1. A composition for treating insomnia, comprising:

(a) between about 1 to 100 mg of vitamin B6;

(b) between about 10 to 300 mg of L-Theanine;

(c) between about 20 to 1000 mg of y-aminobutyric acid (GABA);

(d) between about 1 to 150 mg of 5-Hydroxytryptophan;

(e) between about 0.3 to 5 mg of Melatonin,

(f) between about 100 to 500 mg of chamomile extract:

(g) between about 10 to 300 mg of passionflower extract; and

(h) between about 25 to 250 mg of lemon balm extract.

2. The composition of claim 1 , wherein the composition is provided as a dietary supplement.

3. The composition of claim 1 , wherein the composition is administered orally in the form of a capsule.

4. The composition of claim 1 , wherein the composition is administered orally in the form of a tablet.

5. The composition of claim 1 , wherein the composition is substantially free of at least one of gluten, wheat, eggs, peanuts, tree nuts, dairy, sugar, corn, soy, yeast, artificial colors, preservatives, fish and shellfish.

6. The composition of claim 1 , further comprising at least one palatability agent, and wherein the palatability agent is selected from the group consisting of a plant oil, a plant hydrolysate, yeast, a yeast hydrolysate, and combinations thereof.

7. The composition of claim 1 , wherein the vitamin B6 is pyridoxal-5-phosphate, and comprises about 5 mg of pyridoxal-5-phosphate.

8. The composition of claim 1 , wherein the composition comprises about 100 mg of L-Theanine.

9. The composition of claim 1 , wherein the composition comprises about 100 mg of GABA.

10. The composition of claim 1 , wherein the composition comprises about 50 mg of 5-HTP.

11. The composition of claim 1 , wherein the composition comprises about 1 mg of melatonin.

12. The composition of claim 1 , wherein the chamomile is standardized to 0.4% flavonoids, and wherein the composition comprises about 300 mg of chamomile extract.

13. The composition of claim 1 , wherein the passionflower extract is standardized to 3.5% flavonoids, and wherein the composition comprises about 100 mg of passionflower extract.

14. The composition of claim 1 , wherein the lemon balm extract is standardized to 3% resmarinic acid, and wherein the composition comprises about 100 mg of lemon balm extract.

15. A method for treating sleep-related disorders by administering to a patient in need thereof a therapeutically effective amount of the composition of claim 1 .

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2026
From: SCRIPT ESSENTIALS LLC
To: PANDO LIFE SCIENCES LLC
Reel/Frame 075157/0177 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2022
From: COHEN, SUZY
To: SCRIPT ESSENTIALS, LLC
Reel/Frame 059002/0735 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2018
From: COHEN, SUZY
To: SCRIPT ESSENTIALS, LLC
Reel/Frame 046647/0032 →
Continuity (2)
Provisional Application 62528272 · Jul 3, 2017
Related Publication 20190000907A1 · Jan 3, 2019
Cited By (9)
US 12,213,505 US 12,310,959 US 12,382,982 US 12,433,321 US 12,439,949 US 12,439,952 US 12,520,867 US 12,599,159 US 12,714,701